A Call for Physiopathological Ethics

le Lowenstein, Pedro R
Foilsithe 2008

With a Little Help From My f(X)riends!: The Basis of Ad5-Mediated Transduction of the Liver Revealed

le Lowenstein, Pedro R
Foilsithe 2008

Clinical trials in gene therapy: Ethics of informed consent and the future of experimental medicine

le Lowenstein, Pedro R
Foilsithe 2008

Crossing the Rubicon

le Lowenstein, Pedro R
Foilsithe 2009

Risk in Clinical Research: Size Matters!

le Lowenstein, Pedro R
Foilsithe 2009

Uncertainty in the Translation of Preclinical Experiments to Clinical Trials. Why do Most Phase III Clinical Trials Fail?

le Lowenstein, Pedro R., Castro, Maria G.
Foilsithe 2009

The Value of EGFRvIII as the Target for Glioma Vaccines

le Lowenstein, Pedro R., Castro, Maria G.
Foilsithe in Am Soc Clin Oncol Educ Book (2014)

Gene Therapy Continues to Make Progress: Clinical and Regulatory Perspectives

le Castro, Maria G., Lowenstein, Pedro R.
Foilsithe in Curr Gene Ther (2009)

Glioma trials and viral tribulations: can anything be concluded from non-controlled trials?

le Lowenstein, Pedro R., Castro, Maria G.
Foilsithe in J Neurol Neurosurg Psychiatry (2014)

The Long and Winding Road: from the high affinity choline uptake site to clinical trials for malignant brain tumors

le Lowenstein, Pedro R., Castro, Maria G.
Foilsithe in Adv Pharmacol (2016)

Multiple expressed endogenous glioma epitopes as novel vaccines for gliomas

le Lowenstein, Pedro R., Castro, Maria G.
Foilsithe in Clin Cancer Res (2016)

Evolutionary basis of a new approach for the treatment of malignant brain tumors: from mice to humans

le Lowenstein, Pedro R., Castro, Maria G.
Foilsithe in Clin Immunol (2017)

Immunology of neurological gene therapy: How T cells modulate viral vector-mediated therapeutic transgene expression through immunological synapses

le Lowenstein, Pedro R., Kroeger, Kurt, Castro, Maria G.
Foilsithe 2007

ATRX mutations and glioblastoma: Impaired DNA damage repair, alternative lengthening of telomeres, and genetic instability

le Koschmann, Carl, Lowenstein, Pedro R., Castro, Maria G.
Foilsithe in Mol Cell Oncol (2016)

Efficient Virus Extinction by Combinations of a Mutagen and Antiviral Inhibitors

le Pariente, Nonia, Sierra, Saleta, Lowenstein, Pedro R., Domingo, Esteban
Foilsithe 2001

Response of Foot-and-Mouth Disease Virus to Increased Mutagenesis: Influence of Viral Load and Fitness in Loss of Infectivity

le Sierra, Saleta, Dávila, Mercedes, Lowenstein, Pedro R., Domingo, Esteban
Foilsithe 2000

Challenges in the evaluation, consent, ethics and history of early clinical trials – Implications of the Tuskegee ‘trial’ for safer and more ethical clinical trials

le Lowenstein, Pedro R, Lowenstein, Elijah D, Castro, Maria G
Foilsithe 2009

AAV6-Mediated Gene Silencing fALS Short

le Mandel, Ronald J, Lowenstein, Pedro R, Byrne, Barry J
Foilsithe 2011

Cracking the glioma-NK inhibitory code: toward successful innate immunotherapy

le Lowenstein, Pedro R, Baker, Gregory J, Castro, Maria G
Foilsithe in Oncoimmunology (2014)

Blocking Immunosuppressive Checkpoints for Glioma Therapy: The More the Merrier!

le Castro, Maria G., Baker, Gregory J., Lowenstein, Pedro R.
Foilsithe in Clin Cancer Res (2014)